Marina Biotech Shows Early Data on miRNA Inhibitor Delivery

The oligos were modified with the company's conformationally restricted nucleotide technology, which boosted their melting temperature as much as three degrees, according to a company official.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.